Products

Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir

China Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir, Find details about China Daclatasvir, Anticancer Daclatasvir from Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir

Model NO.
D-Sung Daclatasvir
Product Name
Daclatasvir
Name
Daclatasvir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical Grade
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1009119-65-6
Mf
C40h50n8o6
MW
738.875
Density
1.25
Melting Point
1071.239
Trademark
D-Sung
Transport Package
Negotiabie
Specification
99%
Origin
Shaanxi Xian
Model NO.
D-Sung Daclatasvir
Product Name
Daclatasvir
Name
Daclatasvir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical Grade
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1009119-65-6
Mf
C40h50n8o6
MW
738.875
Density
1.25
Melting Point
1071.239
Trademark
D-Sung
Transport Package
Negotiabie
Specification
99%
Origin
Shaanxi Xian
Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir
Raw Material Ledipasvir Pharmaceutical Daclatasvir powder Anticancer Daclatasvir 
Product Description

Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir

Product Datails

 

Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir
Product NameDaclatasvir 
AppearanceWhite Powder
MfC40h52cl2n8o6
cas1009119-65-6
Shelf Life2 Years
Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection.Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). 
Daclatasvir was discovered as a first-in-class inhibitor of the non-structural viral protein 5A (NS5A), a phosphoprotein that
plays an important role in hepatitis C replication.
Application&Function

Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirSofosbuvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients.
 

Specification

Raw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer DaclatasvirRaw Material Ledipasvir Pharmaceutical Daclatasvir Powder Anticancer Daclatasvir


 

 

You Might Also Like